SILVAFOAM
Dead / Cancelled — Cancelled — Section 8 (as of 30 Dec 2016)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77845628
- Registration number
- 3793035
- Mark type
- Stylized text
- Filed
- 09 Oct 2009
- Published for opposition
- 09 Mar 2010
- Registered
- 25 May 2010
Goods and services
- Class 003 — Cosmetics and cleaning preparations: Foam cleansers for personal use; Skin cleansers
- Class 005 — Pharmaceuticals: Antibacterial pharmaceuticals; Antibacterial substances for medical purposes; Antimicrobial preservatives for cosmetics and pharmaceuticals; Antimicrobials for dermatologic use; Cleansing solutions for medical use; Dermatological pharmaceutical products; Medical cleansers for skin and wounds; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention of microbial/viral colonization and/or infection; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of microbia/viral infection; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceuticals, namely, anti-infectives
Owner
- Molecular Therapeutics, Athens, GA, US
- Molecular Therapeutics, Athens, GA, US
- Molecular Therapeutics, Athens, GA, US
Prosecution history
- 30 Dec 2016 — CANCELLED SEC. 8 (6-YR)
- 25 May 2015 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 25 May 2010 — REGISTERED-PRINCIPAL REGISTER
- 09 Mar 2010 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Mar 2010 — PUBLISHED FOR OPPOSITION
- 04 Feb 2010 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 04 Feb 2010 — ASSIGNED TO LIE
- 12 Jan 2010 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Jan 2010 — ASSIGNED TO EXAMINER
- 15 Oct 2009 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Oct 2009 — NEW APPLICATION ENTERED